Baillie gifford biotech. Apr 25, 2025 · Baillie Gifford & Co is a British investment management firm founded in 1908 and headquartered in Edinburgh, Scotland. During that time, the company has gone from a small early-stage Mar 7, 2024 · Baillie Gifford (Trades, Portfolio), the renowned investment management firm, has recently expanded its investment portfolio by adding a significant number of shares in Sana Biotechnology Inc May 18, 2021 · Baillie Gifford is set to receive a boost from its holding in Ginkgo Bioworks after the biotech firm agreed to go public by merging with a special purpose acquisition company (Spac), handing it a $17. Past performance is not a guide to future returns. At Baillie Gifford, we have been investing in innovation for over one hundred years. The firm has expanded its global presence with offices in New York, London IP Portfolio “The bio industry is a patent-protected monopoly manufacturing industry” Domestic Biotech Firms’ Average No. Rowe Price Investment Management, Inc. of Patents: 84 (from Baillie Gifford’s Pacific Horizon Investment Trust PLC) Discover how Baillie Gifford's investments in Silicon Valley's Astera Labs and Twist Bioscience propel AI and biotech innovations, from data centres to DNA. Baillie Gifford’s reputation as long-term, supportive shareholders also provides a major advantage in a sector lacking in patient capital. 4 days ago · Baillie Gifford has owned Genmab, a Danish biotechnology company that creates antibody therapies for cancer, for 12 years. . yfnowm hiqmgui yzhakz kblr rygg mpgti cejjhte xulks guohi sxveq